Literature DB >> 19283747

Assessment of risk of bias in randomized clinical trials in surgery.

K S Gurusamy1, C Gluud, D Nikolova, B R Davidson.   

Abstract

BACKGROUND: Meta-analysis of randomized clinical trials (RCTs) with low risk of bias is considered the highest level of evidence available for evaluating an intervention. Bias in RCTs may overestimate or underestimate the true effectiveness of an intervention.
METHODS: The causes of bias in surgical trials as described by The Cochrane Collaboration, and the methods that can be used to avoid them, are reviewed.
RESULTS: Blinding is difficult in many surgical trials but careful trial design can reduce the bias risk due to lack of blinding. It is possible to conduct surgical trials with low risk of bias by using appropriate trial design.
CONCLUSION: The risk of providing a treatment based on a biased effect estimate must be balanced against the difficulty of conducting trials with very low risk of bias. Better understanding of the risk of bias may result in improved trials with a closer estimate of the true effectiveness of an intervention. (c) 2009 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.

Mesh:

Year:  2009        PMID: 19283747     DOI: 10.1002/bjs.6558

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  40 in total

Review 1.  Meta-analysis of randomized controlled trials on the effectiveness of somatostatin analogues for pancreatic surgery: a Cochrane review.

Authors:  Rahul S Koti; Kurinchi S Gurusamy; Giuseppe Fusai; Brian R Davidson
Journal:  HPB (Oxford)       Date:  2010-04       Impact factor: 3.647

Review 2.  Current protective strategies in liver surgery.

Authors:  Kurinchi S Gurusamy; Hector D Gonzalez; Brian R Davidson
Journal:  World J Gastroenterol       Date:  2010-12-28       Impact factor: 5.742

Review 3.  Perioperative antiemetic efficacy of dexamethasone versus 5-HT3 receptor antagonists: a meta-analysis and trial sequential analysis of randomized controlled trials.

Authors:  Preet Mohinder Singh; Anuradha Borle; Rajesh Panwar; Jeetinder Kaur Makkar; Ian McGrath; Anjan Trikha; Ashish Sinha
Journal:  Eur J Clin Pharmacol       Date:  2018-06-01       Impact factor: 2.953

4.  EAES recommendations on methodology of innovation management in endoscopic surgery.

Authors:  Edmund A M Neugebauer; Monika Becker; Gerhard F Buess; Alfred Cuschieri; Hans-Peter Dauben; Abe Fingerhut; Karl H Fuchs; Brigitte Habermalz; Leonid Lantsberg; Mario Morino; Stella Reiter-Theil; Gabriela Soskuty; Wolfgang Wayand; Thilo Welsch
Journal:  Surg Endosc       Date:  2010-01-07       Impact factor: 4.584

Review 5.  Pharmacological interventions for ischaemia reperfusion injury in liver resection surgery performed under vascular control.

Authors:  Mahmoud Abu-Amara; Kurinchi Selvan Gurusamy; George Glantzounis; Barry Fuller; Brian R Davidson
Journal:  Cochrane Database Syst Rev       Date:  2009-10-07

Review 6.  Prophylactic gastrojejunostomy for unresectable periampullary carcinoma.

Authors:  Kurinchi Selvan Gurusamy; Senthil Kumar; Brian R Davidson
Journal:  Cochrane Database Syst Rev       Date:  2013-02-28

Review 7.  Propylthiouracil for alcoholic liver disease.

Authors:  Giuseppe Fede; Giacomo Germani; Christian Gluud; Kurinchi Selvan Gurusamy; Andrew K Burroughs
Journal:  Cochrane Database Syst Rev       Date:  2011-06-15

Review 8.  Surgical versus endoscopic treatment of bile duct stones.

Authors:  Bobby V M Dasari; Chuan Jin Tan; Kurinchi Selvan Gurusamy; David J Martin; Gareth Kirk; Lloyd McKie; Tom Diamond; Mark A Taylor
Journal:  Cochrane Database Syst Rev       Date:  2013-12-12

Review 9.  Antibiotics for treating acute chest syndrome in people with sickle cell disease.

Authors:  Arturo J Martí-Carvajal; Lucieni O Conterno; Jennifer M Knight-Madden
Journal:  Cochrane Database Syst Rev       Date:  2015-03-06

10.  Efficiency and Safety Effects of Applying ERAS Protocols to Bariatric Surgery: a Systematic Review with Meta-Analysis and Trial Sequential Analysis of Evidence.

Authors:  Preet Mohinder Singh; Rajesh Panwar; Anuradha Borle; Basavana Goudra; Anjan Trikha; Bart A van Wagensveld; Ashish Sinha
Journal:  Obes Surg       Date:  2017-02       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.